Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant
NCT05982275
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Allogeneic Stem Cell Transplantation
Interventions
GENETIC:
CARTemis-1
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla